Effect of the CYP2D6 genotype on prolactin concentration in schizophrenic patients treated with haloperidol

被引：11
作者：
Yasui-Furukori, N
Kondo, T
Suzuki, A
Mihara, K
Tokinaga, N
Inoue, Y
Otani, K
Kaneko, S
机构：
[1] Hirosaki Univ, Sch Med, Dept Neuropsychiat, Hirosaki, Aomori 036, Japan
[2] Welfide Corp, Pharmaceut Res Div, Fukuoka, Japan
[3] Yamagata Univ, Sch Med, Dept Neuropsychiat, Yamagata 99023, Japan
来源：
SCHIZOPHRENIA RESEARCH | 2001年 / 52卷 / 1-2期
关键词：
D O I：
10.1016/S0920-9964(00)00178-X
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：139 / 142
页数：4
相关论文
共 23 条
[1]   Polymorphic drug oxidation - Relevance to the treatment of psychiatric disorders [J].
Bertilsson, L ;
Dahl, ML .
CNS DRUGS, 1996, 5 (03) :200-223
[2]   METABOLITES OF HALOPERIDOL DISPLAY PREFERENTIAL ACTIVITY AT SIGMA-RECEPTORS COMPARED TO DOPAMINE D-2 RECEPTORS [J].
BOWEN, WD ;
MOSES, EL ;
TOLENTINO, PJ ;
WALKER, JM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 177 (03) :111-118
[3]   GENOTYPING OF POOR METABOLIZERS OF DEBRISOQUINE BY ALLELE-SPECIFIC PCR AMPLIFICATION [J].
HEIM, M ;
MEYER, UA .
LANCET, 1990, 336 (8714) :529-532
[4]   DETERMINATION OF BROMPERIDOL IN SERUM BY AUTOMATED COLUMN-SWITCHING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
HIKIDA, K ;
INOUE, Y ;
MIYAZAKI, T ;
KOJIMA, N ;
OHKURA, Y .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1989, 495 :227-234
[5]  
JOHANSSON I, 1994, MOL PHARMACOL, V46, P452
[6]   HALOPERIDOL DISPOSITION IS DEPENDENT ON THE DEBRISOQUINE HYDROXYLATION PHENOTYPE - INCREASED PLASMA-LEVELS OF THE REDUCED METABOLITE IN POOR METABOLIZERS [J].
LLERENA, A ;
DAHL, ML ;
EKQVIST, B ;
BERTILSSON, L .
THERAPEUTIC DRUG MONITORING, 1992, 14 (03) :261-264
[7]   HALOPERIDOL DISPOSITION IS DEPENDENT ON DEBRISOQUINE HYDROXYLATION PHENOTYPE [J].
LLERENA, A ;
ALM, C ;
DAHL, ML ;
EKQVIST, B ;
BERTILSSON, L .
THERAPEUTIC DRUG MONITORING, 1992, 14 (02) :92-97
[8]   Prolactin response to nemonapride, a selective antagonist for D2 like dopamine receptors, in schizophrenic patients in relation to Taq1A polymorphism of DRD2 gene [J].
Mihara, K ;
Kondo, T ;
Suzuki, A ;
Yasui, N ;
Nagashima, U ;
Ono, S ;
Otani, K ;
Kaneko, S .
PSYCHOPHARMACOLOGY, 2000, 149 (03) :246-250
[9]   Effects of the CYP2D6*10 allele on the steady-state plasma concentrations of haloperidol and reduced haloperidol in Japanese patients with schizophrenia [J].
Mihara, K ;
Suzuki, A ;
Kondo, T ;
Yasui, N ;
Furukori, H ;
Nagashima, U ;
Otani, K ;
Kaneko, S ;
Inoue, Y .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (03) :291-294
[10]   Diagnostic and Statistical Manual of Mental Disorders [J].
Mittal, Vijay A. ;
Walker, Elaine F. .
PSYCHIATRY RESEARCH, 2011, 189 (01) :158-159
123